SCHEMBL7732419

SCHEMBL7732419

CC(C)CCN1C(=O)c2cccc3c(Cl)ccc(c23)C1=O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 2/20 0.71
▸ NFE2L2 Q16236 2/20 0.71
▸ TLR9 Q9NR96 2/20 0.71
▸ ALDH1A1 P00352 6/20 0.68
▸ KDM4E B2RXH2 4/20 0.68
▸ LMNA P02545 2/20 0.68
▸ HPGD P15428 2/20 0.64
▸ L3MBTL1 Q9Y468 3/20 0.57
▸ POLB P06746 4/20 0.56
▸ MAPT P10636 4/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ CYP1A2 P05177 2/20 0.56
▸ ERCC1 P07992 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ ALOX12 P18054 1/20 0.56
▸ FEN1 P39748 1/20 0.56
▸ ERCC4 Q92889 1/20 0.56
▸ TYMS P04818 1/20 0.49
▸ KMT2A Q03164 7/20 0.48
▸ BRD1 O95696 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17726925 0.84 ALDH1A1 (0.78) KEAP1NFE2L2TLR9ALDH1A1KDM4E
SCHEMBL8664259 0.84 KDM4E (0.60) KEAP1NFE2L2TLR9ALDH1A1KDM4E
SCHEMBL23752622 0.83 KEAP1 (0.71) KEAP1NFE2L2TLR9ALDH1A1KDM4E
SCHEMBL11629372 0.82 KDM4E (0.70) KEAP1NFE2L2TLR9ALDH1A1KDM4E
SCHEMBL6887733 0.82 ALDH1A1 (0.74) KEAP1NFE2L2TLR9ALDH1A1KDM4E
SCHEMBL8664264 0.82 KDM4E (0.58) KEAP1NFE2L2TLR9ALDH1A1KDM4E
SCHEMBL7735555 0.81 KDM4E (0.68) KEAP1NFE2L2TLR9ALDH1A1KDM4E
SCHEMBL27461130 0.81 KDM4E (0.68) KEAP1NFE2L2TLR9ALDH1A1KDM4E
SCHEMBL17733959 0.81 KDM4E (0.68) KEAP1NFE2L2TLR9ALDH1A1KDM4E
SCHEMBL6347785 0.81 ALDH1A1 (1.00) KEAP1NFE2L2ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962140-B2 Functionalized core-shell nanoparticles BASF SE (DE) 2015-02-24 — — US disclosed
US-8962140-B2 Functionalized core-shell nanoparticles BASF SE (DE) 2015-02-24 — — US disclosed
US-20130096241-A1 FUNCTIONALIZED NANOPARTICLES BASF SE (DE) 2013-04-18 — — US disclosed
US-20130096241-A1 FUNCTIONALIZED NANOPARTICLES BASF SE (DE) 2013-04-18 — — US disclosed
WO-2011054731-A1 FLUORESCENT MATERIALS BASF SE (DE) 2011-05-12 — — WO disclosed
EP-2144918-B1 FUNCTIONALIZED NANOPARTICLES BASF SE (DE) 2010-11-17 — — EP disclosed
US-20100162494-A1 FUNCTIONALIZED NANOPARTICLES CIBA CORPORATION (US) 2010-07-01 — — US disclosed
US-20100162494-A1 FUNCTIONALIZED NANOPARTICLES CIBA CORPORATION (US) 2010-07-01 — — US disclosed
US-20090099282-A1 Functionalized nanoparticles CIBA SPECIALTY CHEMICALS CORP. 2009-04-16 — — US disclosed
US-20090099282-A1 Functionalized nanoparticles CIBA SPECIALTY CHEMICALS CORP. 2009-04-16 — — US disclosed
WO-2008138727-A1 FUNCTIONALIZED NANOPARTICLES BASF SE (CH) 2008-11-20 — — WO disclosed
US-6403239-B2 MONOMER CONTAINING PHOTOLUMINESCENCE COMPOUND BAYER AG (DE) 2002-06-11 — — US disclosed
US-20010026879-A1 (Co)polymers based on vinyl units and use thereof in electroluminescent devices CHEN YUN (DE) 2001-10-04 — — US disclosed
US-6248457-B1 ELECTROLUMINESCENT COPOLYMER WHICH CONTAINS REPEAT UNITS WITH PHOTOLUMINESCENT RESIDUES BAYER AG (DE) 2001-06-19 — — US disclosed
US-6114463-A Copolymers based on vinyl units and their use in electroluminescent devices BAYER AG (DE) 2000-09-05 — — US disclosed
US-5905128-A (CO) polymers based on vinyl units and use thereof in electroluminescent arrangements BAYER AG (DE) 1999-05-18 — — US disclosed
US-5807945-A (Co)polymers based on vinyl units and use thereof in electroluminescent arrangements BAYER AG (DE) 1998-09-15 — — US disclosed
CN-1151992-A (Co) polymers based on vinyl units and use thereof in electroluminescent arrangements BAYER AG (DE) 1997-06-18 — — CN disclosed
CN-1142510-A (Co) polymers based on vinyl units and use thereof in electroluminescent devices BAYER AG (DE) 1997-02-12 — — CN disclosed
CN-1138036-A 1,8-naphthalimide derviatives, processes for their manufacture and use as intermediates BAYER AG (DE) 1996-12-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100162494-A1 FUNCTIONALIZED NANOPARTICLES TYR, ZKSCAN2, TST KEAP1 1185/4885NFE2L2 1332/4885TLR9 2929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback